Shanghai Chest Hospital: the story yet to be told

Shanghai Chest Hospital: the story yet to be told

Henning A. Gaissert

Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA

Correspondence to: Henning A. Gaissert, MD. Massachusetts General Hospital, Harvard Medical School, 55 Fruit St, Boston, MA 02114, USA. Email: HGAISSERT@PARTNERS.ORG.

Comment on: Wang Y, Gu Z, Yao F, et al. Annual report of thoracic surgery service at Shanghai Chest Hospital in 2021. Shanghai Chest 2023;7:15.

Keywords: Shanghai Chest Hospital; Department of Thoracic Surgery; Department of Oncological Surgery; thoracic surgery; annual report

Received: 07 May 2023; Accepted: 19 May 2023; Published online: 01 June 2023.

doi: 10.21037/shc-23-17

The 2021 report of surgical activities at one of the world’s premier thoracic surgical centers (1) stops a Western reader in his tracks. There is no institutional comparison to the sheer depth of experience in a single year, a collection of operations that by their number would serve as a unique accomplishment for a generation of surgeons anywhere else. Those who visit the Shanghai Chest Hospital, even for a day, leave impressed by one day’s operative schedule and wish to understand the remarkable organization that enables a growing procedural volume year after year, hardly slowed by a pandemic. Who are the people creating a high reliability organization of this magnitude, how do they interact to form their communality of purpose, how do they educate the next generation and how does their clinical work translate into research? To the observer from afar, their report raises so many interesting questions.

The trends in pulmonary resection observed at Shanghai Chest Hospital illustrate ongoing developments seen elsewhere in our specialty. Segmentectomy is on the rise, lobectomy diminishing, complex operations and extended resections are waning to the point of becoming rare, and within strong growth of minimally invasive methods their surgeons currently favor thoracoscopy over robotic assisted procedures. Lung cancer is a different disease now, and one important reason are the screening processes that help in the transition of surgical care from tertiary to successful secondary disease prevention. How referrals of this scale enter the hospital gates and how public or private screening programs are organized and coordinated with the surgical staff is of tremendous interest to the practicing surgeon as we learn to adapt to a new age.

The significance of the Shanghai Chest Hospital could never be appropriately expressed in numbers alone. We are curious to learn in the future how the next generation of thoracic surgeons is educated, and translational research realized, at such a vibrant institution.


Funding: None.


Provenance and Peer Review: This article was commissioned by the editorial office, Shanghai Chest. The article did not undergo external peer review.

Conflicts of Interest: The author has completed the ICMJE uniform disclosure form (available at The author has no conflicts of interest to declare.

Ethical Statement: The author is accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See:


  1. Wang Y, Gu Z, Yao F, et al. Annual report of thoracic surgery service at Shanghai Chest Hospital in 2021. Shanghai Chest 2023;7:15. [Crossref]
doi: 10.21037/shc-23-17
Cite this article as: Gaissert HA. Shanghai Chest Hospital: the story yet to be told. Shanghai Chest 2023;7:21.

Download Citation